Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results symbols : Snynf save search
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 6 d | $14.19 4.49% 230K
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-29 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
ADAG | $2.73 2.5K
|
Manufacturing
| Email alert
Add to watchlist
SNY | News | $47.85 1.49% 920K
|
Health Technology
| Email alert
Add to watchlist
year update financial results
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
DRIO | $1.52 15.15% 95K
|
Health Technology
|
| O: -4.61%
H: 14.48%
C: 5.52%
financial results
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.425 1.7K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Innovent Announces 2023 Annual Results and Business Updates
Published: 2024-03-20 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
business results
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-03-14 (Crawled : 21:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
CTSO | $0.815 0.62% 27K
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: -8.33%
year results
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
IPHA | $2.425 1.7K
|
Health Technology
|
| O: -2.4%
H: 3.69%
C: 3.28%
pharma conference year financial results
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | News | $0.535 4.88% 1.8M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
Published: 2024-03-11 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
dermatitis response potential results
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
MGNX | $16.485 6.98% 250K
|
Health Technology
|
| O: -5.7%
H: 11.12%
C: -9.88%
update financial results
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
IGMS | $7.545 11.78% 160K
|
Health Technology
|
| O: 2.14%
H: 9.69%
C: 0.97%
year update financial results
Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024
Published: 2024-03-07 (Crawled : 04:00) - prnewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
ibi311 congress international results
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
ALNY | $146.64 0.58% 200K
|
Health Technology
|
| O: -0.73%
H: 1.52%
C: 0.5%
positive blood care topline results study
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
MLTX | $42.71 4.12% 220K
|
|
| O: 1.3%
H: 0.0%
C: -16.18%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
day business year financial
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
INBX | $34.21 0.32% 68K
|
Health Technology
|
| O: -0.86%
H: 0.13%
C: -5.66%
year financial results
Full-year 2023 results
Published: 2024-02-28 (Crawled : 18:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
results
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
DNLI | $16.37 2.38% 360K
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
business year therapeutics financial results
Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
pharma year financial results
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
Published: 2024-02-26 (Crawled : 21:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
RVMD | $36.68 0.69% 620K
|
Health Technology
|
| O: 4.15%
H: 2.04%
C: -3.22%
year update financial results
Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
Published: 2024-02-24 (Crawled : 16:20) - globenewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
disease urticaria results
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.